敗血症診断の世界市場予測(~2021年)

◆英語タイトル:Sepsis Diagnostics Market by Technology (Molecular Diagnostics, Microbiology, Immunoassay), Product (Instrument, Blood Culture Media), Method (Conventional & Automated), Usability (Laboratory & POC), Pathogen (Bacterial & Fungal) - Global Forecast to 2021
◆商品コード:MAM-MD-4575
◆発行会社(調査会社):MarketsandMarkets
◆発行日:2016年9月15日
◆ページ数:176
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥644,100見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥758,100見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥929,100見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※レポート購入後、該当レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarkets社の日本における正規販売代理店です。MarketsandMarkets社の概要及び新刊レポートはこちらでご確認いただけます。



当調査レポートでは、敗血症診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、技術別分析、製品別分析、方式別分析、地域別分析、敗血症診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。
【レポートの概要】

The global sepsis diagnostics market is expected to reach USD 564.1 Million by 2021 from USD 370.0 Million in 2016, growing at a CAGR of 8.8% between 2016 and 2021.
On the basis of products, the global sepsis diagnostics market is segmented into 4 broad categories, namely, blood culture media, assay kits & reagents, instruments, and software. The blood culture media market is estimated to command the largest share of the global sepsis diagnostics market in 2016. The large share of this segment can be attributed to the high use of blood culture testing as the standard diagnostic method for the diagnosis and identification of sepsis. The global assay kits & reagents segment, on the other hand, is expected hold the second largest share in the sepsis diagnostics market. Increasing adoption of assay based kits and growing approvals for assay kit products across the globe is fueling the growth of the assay kits & reagents market.

On the basis of technology, the market is segmented into four major technologies, namely, microbiology, immunoassays, molecular diagnostics, and flow cytometry. The microbiology segment holds the largest share in the sepsis diagnostics market and is expected to grow at a high CAGR during the forecast period. The global molecular diagnostic segment is expected to grow at the highest CAGR from 2016 to 2021. Its growth can be attributed to the increasing inclination of physicians and patients towards use of rapid diagnostic products for accurate and quick identification and diagnosis of sepsis.

The sepsis diagnostics market is categorized into two segments, namely, conventional diagnostics and automated diagnostics. The conventional diagnostics segment is estimated to command the larger share of the global sepsis diagnostics market in 2016. The growth of this segment can be attributed to the high adoption of this method for sepsis diagnosis, due to the ease, and presence of long-term/established clinical evidences.

On the basis of usability, the sepsis diagnostics market is further segmented into laboratory testing and point-of-care testing. The laboratory testing segment is expected to account for a larger share of the sepsis diagnostics market in 2016. The large share of this segment can be attributed to the high use of conventional blood culture tests for sepsis diagnosis, lack of awareness about POC sepsis diagnosis devices, and low cost of laboratory testing services.

The sepsis diagnostics market on the basis of pathogen is segmented into bacterial sepsis, fungal sepsis, and other infectious pathogens (viral and parasitic infection). The bacterial sepsis segment is expected to account for a larger share of the sepsis diagnostics market in 2016.

On the basis of geography, this market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2016, the global sepsis diagnostics market is estimated to be dominated by North America. A number of factors such as high prevalence of sepsis, rising number of invasive procedures, growing adoption of high-end sepsis diagnostics devices, and rising government support towards sepsis researches are driving the growth of the North American sepsis diagnostics market. The Asia-Pacific market is expected to grow at the highest CAGR from 2016 to 2021. Factors such as increasing number of surgical procedures, growing number of clinical studies, developing healthcare infrastructure, and rising focus of global players are the key factors stimulating the growth of the sepsis diagnostics market in the Asia-Pacific nations are propelling the growth of the sepsis diagnostics market. In the region

bioMérieux SA (France), T2 Biosystems, Inc. (U.S.), Cepheid (U.S.), Thermo Fisher Scientific Inc. (U.S.), Nanosphere, Inc. (U.S.), Abbott Laboratories, Inc. (U.S.), Roche Diagnostics Limited (Switzerland), Becton, Dickinson and Company (U.S.), Bruker Corporation (U.S.), and Beckman Coulter, Inc. (U.S.) are some of the key players operating in the global sepsis diagnostics market.

【レポートの目次】

1 Introduction (Page No. – 17)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.4 Markets Covered
1.4.1 Years Considered for the Study
1.5 Currency
1.6 Limitations
1.7 Stakeholders

2 Research Methodology (Page No. – 20)
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.3 Market Size Estimation Methodology
2.1.3.1 Bottom-Up Approach
2.1.3.2 Top-Down Approach
2.1.4 Research Design
2.1.5 Market Data Validation and Triangulation
2.1.6 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 34)
4.1 Attractive Market Opportunities in the Global Sepsis Diagnostics
4.2 Geographic Analysis: Sepsis Diagnostics Market, By Product
4.3 Sepsis Diagnostics Market Size, By Technology, 2016 vs 2021
4.4 Sepsis Diagnostics Market Size, By Method and Region, 2016
4.5 Sepsis Diagnostics Market Size, By USAbility, 2016 vs 2021
4.6 Sepsis Diagnostics Market Size, By Pathogen, 2016 vs 2021

5 Market Overview (Page No. – 39)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 High Prevalence of Sepsis in the Neonate and Adult Population
5.2.1.2 Rising Incidence of Sepsis in Geriatric Population
5.2.1.3 Increasing Number of Preterm Births
5.2.1.4 Growing Incidence of Hospital-Acquired Infections
5.2.1.5 Increasing Number of Surgical Procedures
5.2.1.6 Growing Pneumonia Cases
5.2.1.7 Influx of Novel Sepsis Diagnostic Products
5.2.2 Restraints
5.2.2.1 High Cost of Automated Diagnostic Devices
5.2.2.2 Lack of Established Reimbursement for Sepsis
5.2.3 Opportunities
5.2.3.1 Increasing Funding for Sepsis-Related Research Activities
5.2.3.2 Development of Rapid Diagnostic Techniques for Early Sepsis Diagnosis
5.2.3.3 Evolution of Procalcitonin Test as A Novel Biomarker for Sepsis Diagnosis
5.2.3.4 Rising Initiatives to Increase the Awareness and Drive the Adoption of Sepsis Diagnostic Tests
5.2.3.5 Growing Number of Regulatory Approvals for Sepsis Diagnostic Products
5.2.4 Challenges
5.2.4.1 Lack of Standard Protocols and Awareness for Sepsis Diagnosis and Treatment
5.2.4.2 Shortage of Skilled Healthcare Professionals

6 Sepsis Diagnostics Market, By Product (Page No. – 49)
6.1 Introduction
6.2 Instruments
6.3 Blood Culture Media
6.4 Assay Kits & Reagents
6.5 Software

7 Sepsis Diagnostics Market, By Technology (Page No. – 57)
7.1 Introduction
7.2 Microbiology
7.3 Molecular Diagnostics
7.4 Immunoassays
7.5 Flow Cytometry

8 Sepsis Diagnostics Market, By Method (Page No. – 66)
8.1 Introduction
8.2 Conventional Diagnostics
8.3 Automated Diagnostics

9 Sepsis Diagnostics Market, By USAbility (Page No. – 72)
9.1 Introduction
9.2 Laboratory Testing
9.3 Point-Of-Care Testing

10 Sepsis Diagnostics Market, By Pathogen (Page No. – 78)
10.1 Introduction
10.2 Bacterial Sepsis
10.2.1 Gram-Negative Bacterial Sepsis
10.2.2 Gram-Positive Bacterial Sepsis
10.3 Fungal Sepsis
10.4 Other Pathogen Infections

11 Sepsis Diagnostics Market, By Region (Page No. – 86)
11.1 Introduction
11.2 North America
11.2.1 U.S.
11.2.1.1 Growing Prevalence of Sepsis
11.2.1.2 Increasing Incidences of Hais
11.2.1.3 Increasing Government Support for Sepsis Research
11.2.1.4 Growing Product Approvals
11.2.1.5 Rising Initiatives to Drive the Adoption of Sepsis Diagnostic Tools
11.2.1.6 Lack of Standard Protocol for Sepsis Diagnosis Hinders Market Growth
11.2.1.7 High Cost of Treatment
11.2.2 Canada
11.2.2.1 Expanding Patient Population Base
11.2.2.2 Support for the Development of Novel Sepsis Diagnostic Products
11.2.2.3 Growing Focus on Sepsis Management
11.2.2.4 Low Awareness Related to Sepsis Management
11.2.2.5 Dearth of Training Leading to Inadequate Patient Assessment
11.3 Europe
11.3.1 Germany
11.3.1.1 High Incidence of Sepsis
11.3.1.2 Growing Funding for Sepsis Research
11.3.1.3 Initiatives By the German Sepsis Society
11.3.1.4 High Awareness Related to the Sepsis Management
11.3.1.5 Development of Novel Sepsis Diagnostics Products
11.3.1.6 Poor Implementation of Guidelines Related to the Sepsis Management
11.3.2 U.K.
11.3.2.1 Growing Initiatives By Government Organizations
11.3.2.2 Increasing Awareness Among Medical Staff and General Practitioners
11.3.2.3 Rising Focus Towards the Development of New Sepsis Diagnostics Devices
11.3.2.4 Rising Demand for Diagnostic Devices
11.3.2.5 Dearth of Paramedics
11.3.3 France
11.3.3.1 Growing Number of Symposiums and Conferences
11.3.3.2 High Prevalence of Sepsis
11.3.3.3 Growth in Research Funding for Sepsis Diagnosis
11.3.4 Rest of Europe (RoE)
11.3.4.1 Hub for Various Sepsis Related Conferences
11.3.4.2 Rapid Growth in the Aging Population
11.3.4.3 Initiatives to Diagnose Neonatal Sepsis
11.3.4.4 Rising Focus on the Development of Advanced Products
11.4 Asia-Pacific
11.4.1 Japan
11.4.1.1 Increasing Incidence of Healthcare-Associated Infections
11.4.1.2 Growing Aging Population
11.4.1.3 Increasing Initiatives By Market Players
11.4.1.4 Lack of Proper Reimbursement for Sepsis
11.4.2 China
11.4.2.1 Large Number of Ongoing Clinical Studies
11.4.2.2 Developing Healthcare Infrastructure
11.4.2.3 Limited Implementation of Surviving Sepsis Campaign (SSC)
11.4.3 India
11.4.3.1 High Sepsis Burden
11.4.3.2 Rising Antibiotic Resistance
11.4.3.3 Rising Number of Icu Patients
11.4.3.4 Increasing Number of Surgical Procedures
11.4.3.5 Rising Focus of Local and Global Players
11.4.3.6 Shortage of Medical Staff in India
11.4.3.7 Lack of Awareness Leading to Death Due to Sepsis
11.4.4 Rest of Asia-Pacific
11.4.4.1 Large Number of Ongoing Conferences
11.4.4.2 Rising Initiatives to Increase Awareness About Sepsis
11.4.4.3 Significant Patient Population Base in Malaysia
11.4.4.4 South Korea Presents Significant Growth Opportunities
11.4.4.5 Lack of Established Sepsis Management Guidelines
11.4.4.6 Lack of Reimbursement for Sepsis
11.5 Rest of the World
11.5.1.1 Increasing Antibiotic Resistance Among Patients
11.5.1.2 Initiatives to Improve Healthcare in Middle East Countries
11.5.1.3 High Prevalence of Cancer and Hiv in the Region
11.5.1.4 Key Challenges to Market Growth in the Region

12 Competitive Landscape (Page No. – 135)
12.1 Overview
12.2 Market Share Analysis
12.3 Competitive Situation and Trends
12.3.1 Product Approvals
12.3.2 Collaborations, Acquisitions, and Partnerships
12.3.3 New Product Launches
12.3.4 Other Strategies

13 Company Profiles (Page No. – 141)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
13.1 Introduction
13.2 Biomérieux SA
13.3 Becton, Dickinson and Company
13.4 Thermo Fisher Scientific Inc.
13.5 Abbott Laboratories, Inc.
13.6 Roche Diagnostics Limited (A Subsidiary of F. Hoffmann-La Roche Ltd.)
13.7 Cepheid Inc.
13.8 T2 Biosystems, Inc.
13.9 Beckman Coulter, Inc. (A Subsidiary of Danaher Corporation)
13.10 Nanosphere, Inc. (A Luminex Company)
13.11 Bruker Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

14 Appendix (Page No. – 165)
14.1 Discussion Guide
14.2 Other Developments
14.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.4 Introducing RT : Real-Time Market Intelligence
14.5 Available Customizations
14.6 Related Reports

List of Tables (100 Tables)

Table 1 Sepsis Diagnostics Market Size, By Product, 2014-2021 (USD Million)
Table 2 Sepsis Diagnostic Instruments Market Size, By Region, 2014-2021 (USD Million)
Table 3 Blood Culture Media Market Size, By Region, 2014-2021 (USD Million)
Table 4 Assay Kits & Reagents Market Size, By Region, 2014-2021 (USD Million)
Table 5 Software Market Size, By Region, 2014-2021 (USD Million)
Table 6 Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 7 Microbiology Market Size, By Region, 2014–2021 (USD Million)
Table 8 Molecular Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 9 Immunoassays Market Size, By Region, 2014–2021 (USD Million)
Table 10 Flow Cytometry Market Size, By Region, 2014–2021 (USD Million)
Table 11 Sepsis Diagnostics Market Size, By Method, 2014-2021 (USD Million)
Table 12 Conventional Diagnostics Market Size, By Region, 2014-2021 (USD Million)
Table 13 Automated Diagnostic Market Size, By Region, 2014–2021 (USD Million)
Table 14 Sepsis Diagnostics Market Size, By Usability, 2014-2021 (USD Million)
Table 15 Parameters Tested in Sepsis Diagnosis
Table 16 Laboratory Testing Market Size, By Region, 2014-2021 (USD Million)
Table 17 Point-Of-Care Testing Market Size, By Region, 2014-2021 (USD Million)
Table 18 Sepsis Diagnostics Market Size, By Pathogen, 2014-2021 (USD Million)
Table 19 Bacterial Sepsis Market Size, By Type, 2014-2021 (USD Million)
Table 20 Bacterial Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 21 Fungal Sepsis Market Size, By Region, 2014-2021 (USD Million)
Table 22 Other Pathogen Infections Market Size, By Region, 2014-2021 (USD Million)
Table 23 Sepsis Diagnostics Market Size, By Region, 2014–2021 (USD Million)
Table 24 North America: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 25 North America: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 26 North America: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 27 North America: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 28 North America: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 29 North America: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 30 U.S.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 31 U.S.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 32 U.S.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 33 U.S.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 34 U.S.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 35 Canada: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 36 Canada: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 37 Canada: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 38 Canada: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 39 Canada: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 40 Europe: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 41 Europe: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 42 Europe: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 43 Europe: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 44 Europe: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 45 Europe: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 46 Germany: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 47 Germany: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 48 Germany: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 49 Germany: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 50 Germany: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 51 U.K.: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 52 U.K.: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 53 U.K.: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 54 U.K.: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 55 U.K.: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 56 France: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 57 France: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 58 France: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 59 France: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 60 France: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 61 RoE: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 62 RoE: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 63 RoE: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 64 RoE: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 65 RoE: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 66 APAC: Sepsis Diagnostics Market Size, By Country, 2014–2021 (USD Million)
Table 67 APAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 68 APAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 69 APAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 70 APAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 71 APAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 72 Japan: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 73 Japan: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 74 Japan: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 75 Japan: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 76 Japan: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 77 China: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 78 China: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 79 China: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 80 China: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 81 China: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 82 India: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 83 India: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 84 India: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 85 India: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 86 India: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 87 RoAPAC: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 88 RoAPAC: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 89 RoAPAC: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 90 RoAPAC: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 91 RoAPAC: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 92 RoW: Sepsis Diagnostics Market Size, By Technology, 2014–2021 (USD Million)
Table 93 RoW: Sepsis Diagnostics Market Size, By Product, 2014–2021 (USD Million)
Table 94 RoW: Sepsis Diagnostics Market Size, By Pathogen, 2014–2021 (USD Million)
Table 95 RoW: Sepsis Diagnostics Market Size, By Method, 2014–2021 (USD Million)
Table 96 RoW: Sepsis Diagnostics Market Size, By Usability, 2014–2021 (USD Million)
Table 97 Top 5 Product Approvals, 2013–2016
Table 98 Top 5 Collaborations, Acquisition, and Partnerships, 2013–2016
Table 99 Top 4 New Product Launches, 2013–2016
Table 100 Top 5 Other Strategies, 2013–2016


List of Figures (58 Figures)

Figure 1 Sepsis Diagnostics Market Segmentation
Figure 2 Global Sepsis Diagnostics Market: Research Methodology Steps
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Top-Down Approach
Figure 5 Data Triangulation Methodology
Figure 6 Global Sepsis Diagnostics Market, By Product, 2016
Figure 7 Global Sepsis Diagnostics Market, By Technology, 2016 (USD Million)
Figure 8 Global Sepsis Diagnostics Market, By Method, 2016 vs 2021
Figure 9 Global Sepsis Diagnostics Market, By Usability, 2016 vs 2021
Figure 10 Global Sepsis Diagnostics Market, By Pathogen, 2016 vs 2021
Figure 11 Global Sepsis Diagnostics Market, By Region, 2016 (USD Million)
Figure 12 Increasing Prevalence of Sepsis—Primary Driver of the Sepsis Diagnostics Market
Figure 13 Blood Culture Media Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 14 Microbiology Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 15 Conventional Diagnostics Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 16 Laboratory Testing Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 17 Bacterial Sepsis Segment to Dominate the Global Sepsis Diagnostics Market in 2016
Figure 18 Sepsis Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Chances of Developing Sepsis Increase With Age, 2014
Figure 20 Patient Survival Rate in Sepsis Cases
Figure 21 Blood Culture Media Segment to Witness Higher Growth During the Forecast Period (2016- 2021)
Figure 22 North America to Dominate the Instruments Market in 2016
Figure 23 Asia-Pacific to Witness Highest Growth in the Blood Culture Media Market, 2016
Figure 24 North America to Dominate the Assay Kits & Reagents Market in 2016
Figure 25 Asia-Pacific to Witness Highest Growth in the Software Segment (2016-2021)
Figure 26 Molecular Diagnostics Segment to Witness High Growth During the Forecast Period (2016-2021)
Figure 27 North America to Dominate the Microbiology Market in 2016
Figure 28 Asia-Pacific to Witness Highest Growth in the Molecular Diagnostics Market in 2016
Figure 29 North America to Dominate the Immunoassays Market in 2016
Figure 30 North America to Dominate the Flow Cytometry Market in 2016
Figure 31 Conventional Diagnostics Segment Will Continue to Dominate the Sepsis Diagnostics Market in 2021
Figure 32 North America to Dominate the Conventional Diagnostics Market in 2016
Figure 33 Asia-Pacific to Witness High Growth in the Automated Diagnostics Segment During the Forecast Period, 2016-2021
Figure 34 POCT Segment to Witness Highest Growth During the Forecast Period, 2016-2021
Figure 35 North America to Dominate the Laboratory Testing Market in 2016
Figure 36 Asia-Pacific to Witness Highest Growth in the Point-Of-Care Testing Segment (2016-2021)
Figure 37 Bacterial Sepsis Segment to Witness Highest Growth, 2016–2021
Figure 38 Gram-Negative Bacteria Segment to Dominate the Bacterial Sepsis Market in 2016
Figure 39 Asia-Pacific to Witness Higher Growth During the Forecast Period, (2016-2021)
Figure 40 North America to Dominate the Fungal Sepsis Market in 2016
Figure 41 Asia-Pacific to Witness Highest Growth in the Other Pathogens Segment in 2016
Figure 42 Sepsis Diagnostics Market: Growth Forecast, By Region (2016–2021)
Figure 43 North America: Sepsis Diagnostics Market Snapshot
Figure 44 Europe: Sepsis Diagnostics Market Snapshot
Figure 45 APAC: Sepsis Diagnostics Market Snapshot
Figure 46 Global Sepsis Diagnostics Market Share Analysis, By Key Player, 2015
Figure 47 Battle for Market Share: Product Approvals the Key Strategy
Figure 48 Geographic Revenue Mix of the Top Players
Figure 49 Biomérieux Sa: Company Snapshot
Figure 50 Becton, Dickinson and Company: Company Snapshot
Figure 51 Thermo Fisher Scientific Inc.: Company Snapshot
Figure 52 Abbott Laboratories, Inc.: Company Snapshot
Figure 53 Roche Diagnostics Limited: Company Snapshot
Figure 54 Cepheid: Company Snapshot
Figure 55 T2 Biosystems, Inc.: Company Snapshot
Figure 56 Danaher Corporation: Company Snapshot
Figure 57 Luminex Corporation: Company Snapshot
Figure 58 Bruker Corporation: Company Snapshot

【レポートのキーワード】

敗血症診断、敗血症診断技術、敗血症検査、分子診断、微生物、免疫検定、血液培養、敗血症診断装置

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチ(株)はその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチ(株)が翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

★調査レポート[敗血症診断の世界市場予測(~2021年)]についてメールでお問い合わせはこちら


※世界の市場調査資料 総合販売サイトMarketReport.jpはH&Iグローバルリサーチ株式会社が運営しております。海外進出、グローバル事業戦略策定、新規事業機会の発掘、競合他社の動向把握などに必要な情報やインサイトをお客様にご提供しております。H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。
※当サイトでは2016年12月07日現在 219,203 件の調査レポートを取り扱っております。当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。

◆H&Iグローバルリサーチのお客様(例)◆